Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease

GG Camici, G Savarese, A Akhmedov… - European heart …, 2015 - academic.oup.com
… , the prevalence of cardiovascular (CV) and cerebrovascular (CBV) diseases rises with
age. … the molecular pathways of aging as well as age-associated CV and CBV diseases. …

Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease–an overview

V Selvaraju, M Joshi, S Suresh… - … mechanisms and …, 2012 - Taylor & Francis
… oxidative stress are hallmarks of the molecular mechanisms responsible for cardiovascular
disease. Among several oxidative stress-mediated mechanisms that have been proposed, …

Molecular mechanisms of vascular effects of high‐density lipoprotein: alterations in cardiovascular disease

C Besler, TF Lüscher, U Landmesser - EMBO molecular medicine, 2012 - embopress.org
Low high‐density lipoprotein (HDL)‐cholesterol levels are associated with an increased risk
of coronary artery disease (CAD) and myocardial infarction, which has triggered the …

Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease.

JL Dinerman, CJ Lowenstein, SH Snyder - Circulation Research, 1993 - Am Heart Assoc
… NO in Cardiovascular Disease … additional mechanisms through which NO affects blood
pressure.64 Clinical studies suggesting abnormalitiesin the NO system in cardiovascular disease

Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link

L Lavie, P Lavie - European Respiratory Journal, 2009 - Eur Respiratory Soc
… Circulating adhesion molecules released from the endothelium are considered as markers
of active atherosclerotic diseases and as predictors of future cardiovascular disease 81. …

[HTML][HTML] Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective

W Yu, JD Cheng - Frontiers in pharmacology, 2020 - frontiersin.org
… on the latest cellular and molecular findings of cardiovascular disease associated with
hyperuricemia and clinical data about the efficacy of ULT in patients with cardiovascular disease. …

Biomarkers of cardiovascular disease: molecular basis and practical considerations

RS Vasan - Circulation, 2006 - Am Heart Assoc
… conditions promptly and accurately, and to effectively prognosticate and treat patients with
disease. This review provides an overview of the molecular basis of biomarker discovery and …

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications

CE Berry, JM Hare - The Journal of physiology, 2004 - Wiley Online Library
… pathophysiology of cardiovascular disease. Biochemical, molecular and pharmacological …
) as a source of reactive oxygen species in the cardiovascular system. XOR is a member of the …

Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications

J Steffel, TF Lüscher, FC Tanner - Circulation, 2006 - Am Heart Assoc
… involved in the pathogenesis of cardiovascular diseases. Therefore, therapeutic strategies
molecular regulation of TF expression emphasizing the role of TF in cardiovascular diseases

n-3 Fatty acids and cardiovascular disease: Actions and molecular mechanisms

C Torrejon, UJ Jung, RJ Deckelbaum - Prostaglandins, leukotrienes and …, 2007 - Elsevier
… , cardiac excitability, platelet function, triglyceride blood levels, blood pressure and the stability
of atheroma plaques. The molecular mechanisms … and elucidating these mechanisms is …